bunazosin has been researched along with ng-nitroarginine methyl ester in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, K; Ichiki, T; Katoh, M; Takeshita, A; Usui, M | 1 |
| Goto, W; Ikeda, T; Oku, H; Okuno, T; Sugiyama, T | 1 |
| Maehara, K; Maruyama, Y; Oikawa, Y; Saito, T; Tamagawa, K; Yaoita, H | 1 |
3 other study(ies) available for bunazosin and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.
Topics: Adrenal Glands; Adrenergic alpha-Antagonists; Aldosterone; Animals; Blotting, Northern; Body Weight; DNA, Complementary; Enzyme Inhibitors; Gene Expression Regulation; Hemodynamics; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Quinazolines; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; RNA, Messenger | 1998 |
Amelioration by topical bunazosin hydrochloride of the impairment in ocular blood flow caused by nitric oxide synthase inhibition in rabbits.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Evoked Potentials, Visual; Fundus Oculi; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Optic Disk; Quinazolines; Rabbits; Reaction Time; Regional Blood Flow; Vision, Ocular | 2003 |
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Cineangiography; Coronary Angiography; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Heart Failure; Injections, Intra-Arterial; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Propranolol; Quinazolines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vascular Resistance; Vasodilation; Yohimbine | 2005 |